FrankEderMD

Family Medicine • Binghamton, NY

Lead physician upper front street Medical directer of EHR Principal investigator Meridian Clinical Research

Join to view full profile

Dr. Eder is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Eder's full profile

Already have an account?

Office
1290 Upper Front St
Binghamton, NY 13901
Phone+1 607-722-3417
Is this information wrong?

Education & Training

United Health Services HospitalsResidency, Family Medicine, 1993 - 1996
State University of New York Downstate Medical Center College of MedicineClass of 1993

Certifications & Licensure

NY State Medical License 1994 - 2026
American Board of Family Medicine Family Medicine

Publications & Presentations

PubMed

61 citations
Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial.
Spyros Chalkias, Frank Eder, Brandon Essink, Shishir Khetan, Biliana Nestorova, Jing Feng, Xing Chen, Ying Chang, Honghong Zhou, David Montefiori, Darin K Edwards, Bet...> ;Nature Medicine. 2022 Nov 1
325 citations
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase.
Hana M. El Sahly, Lindsey R. Baden, Brandon Essink, Susanne Doblecki-Lewis, Judith M. Martin, Evan J. Anderson, Thomas B. Campbell, Jesse L. Clark, Lisa A. Jackson, Ca...> ;The New England Journal of Medicine. 2021 Sep 22
1328 citations
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19.
Jerald C. Sadoff, Glenda Gray, An Vandebosch, Vicky Cardenas, Georgi Shukarev, Beatriz Grinsztejn, Paul A. Goepfert, Carla Truyers, Hein Fennema, Bart Spiessens, Kim O...> ;The New England Journal of Medicine. 2021 Apr 21
Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease: Results From the CREDENCE Trial and Meta-Analysis.
Zhou Z, Jardine MJ, Li Q, Neuen BL, Cannon CP, de Zeeuw D, Edwards R, Levin A, Mahaffey KW, Perkovic V, Neal B, Lindley RI, CREDENCE Trial Investigators*> ;Stroke. 2021-04-20
Efficacy and Safety of the mRNA-1273 SARS-CoV-2 Vaccine.
Baden LR, El Sahly HM, Essink B, Kotloff K, Frey S, Novak R, Diemert D, Spector SA, Rouphael N, Creech CB, McGettigan J, Khetan S, Segall N, Solis J, Brosz A, Fierro C...> ;The New England journal of medicine. 2020-12-30
Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.
Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, Moreira ED, Zerbini C, Bailey R, Swanson KA, Roychoudhury S, Koury K, Li P, ...> ;The New England journal of medicine. 2020-12-10
Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol.
Ray KK, Wright RS, Kallend D, Koenig W, Leiter LA, Raal FJ, Bisch JA, Richardson T, Jaros M, Wijngaard PLJ, Kastelein JJP, ORION-10 and ORION-11 Investigators> ;The New England journal of medicine. 2020-03-18
Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo-...
Bhatt DL, Steg PG, Mehta SR, Leiter LA, Simon T, Fox K, Held C, Andersson M, Himmelmann A, Ridderstråle W, Chen J, Song Y, Diaz R, Goto S, James SK, Ray KK, Parkhomenk...> ;Lancet (London, England). 2019-09-01
The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics.
Jardine MJ, Mahaffey KW, Neal B, Agarwal R, Bakris GL, Brenner BM, Bull S, Cannon CP, Charytan DM, de Zeeuw D, Edwards R, Greene T, Heerspink HJL, Levin A, Pollock C, ...> ;American journal of nephrology. 2017-12-13
Join now to see all